Tags

Type your tag names separated by a space and hit enter

Eslicarbazepine for focal epilepsy and acute intermittent porphyria.
Epileptic Disord. 2020 Jun 01; 22(3):349-352.ED

Abstract

Porphyrias are rare genetic disorders which cause a deficiency in the enzymes involved in the biosynthesis of heme. The treatment of epilepsy in patients with acute intermittent porphyria can be difficult since many anticonvulsants can increase heme synthesis and trigger porphyric attacks. We report a patient with focal epilepsy successfully treated with eslicarbazepine without exacerbation of porphyria.

Authors+Show Affiliations

University of Montreal Hospital Center, Montreal, Quebec, Canada.University of Montreal Hospital Center, Montreal, Quebec, Canada.University of Montreal Hospital Center, Montreal, Quebec, Canada.University of Montreal Hospital Center, Montreal, Quebec, Canada.University of Montreal Hospital Center, Montreal, Quebec, Canada.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32554360

Citation

Herrera-Fortin, Tamara, et al. "Eslicarbazepine for Focal Epilepsy and Acute Intermittent Porphyria." Epileptic Disorders : International Epilepsy Journal With Videotape, vol. 22, no. 3, 2020, pp. 349-352.
Herrera-Fortin T, Pana R, Wesolowska E, et al. Eslicarbazepine for focal epilepsy and acute intermittent porphyria. Epileptic Disord. 2020;22(3):349-352.
Herrera-Fortin, T., Pana, R., Wesolowska, E., Bourré-Tessier, J., & Nguyen, D. K. (2020). Eslicarbazepine for focal epilepsy and acute intermittent porphyria. Epileptic Disorders : International Epilepsy Journal With Videotape, 22(3), 349-352. https://doi.org/10.1684/epd.2020.1171
Herrera-Fortin T, et al. Eslicarbazepine for Focal Epilepsy and Acute Intermittent Porphyria. Epileptic Disord. 2020 Jun 1;22(3):349-352. PubMed PMID: 32554360.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Eslicarbazepine for focal epilepsy and acute intermittent porphyria. AU - Herrera-Fortin,Tamara, AU - Pana,Raluca, AU - Wesolowska,Ewa, AU - Bourré-Tessier,Josiane, AU - Nguyen,Dang K, PY - 2020/6/20/pubmed PY - 2020/6/20/medline PY - 2020/6/20/entrez KW - carbamazepine KW - eslicarbazepine KW - hepatic porphyria SP - 349 EP - 352 JF - Epileptic disorders : international epilepsy journal with videotape JO - Epileptic Disord VL - 22 IS - 3 N2 - Porphyrias are rare genetic disorders which cause a deficiency in the enzymes involved in the biosynthesis of heme. The treatment of epilepsy in patients with acute intermittent porphyria can be difficult since many anticonvulsants can increase heme synthesis and trigger porphyric attacks. We report a patient with focal epilepsy successfully treated with eslicarbazepine without exacerbation of porphyria. SN - 1950-6945 UR - https://www.unboundmedicine.com/medline/citation/32554360/Eslicarbazepine_for_focal_epilepsy_and_acute_intermittent_porphyria L2 - http://www.john-libbey-eurotext.fr/medline.md?doi=10.1684/epd.2020.1171 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.